ISM-1 expression in cutaneous mastocytosis: Diagnostic potential and comparison with CD117

Read full text
Authors: Şeyhmus Kaya, İbrahim İbiloğlu, Ramazan Oğuz Yüceer, Mustafa Tosun, Tülay Koç, Hatice Reyhan Eğilmez
Cited by: 1
References: 21

Abstract

Isthmin-1 (ISM-1) is a multifunctional secreted protein expressed in various tissues, exhibiting biological activities that overlap with mast cell functions. To date, no study has demonstrated its expression in mast cells. This study presents the first evidence of ISM-1 immunoreactivity in mast cells and investigates its diagnostic relevance in cutaneous mastocytosis. Thirty-nine patients diagnosed with cutaneous mastocytosis from 2 tertiary centers were retrospectively evaluated. Formalin-fixed paraffin-embedded skin biopsy specimens were immunohistochemically stained using antibodies against ISM-1 and CD117. Expression levels were semiquantitatively scored, and associations with clinical, histopathological, and demographic variables were statistically analyzed. All cases exhibited ISM-1 positivity, with 69.2% demonstrating high expression. Notably, ISM-1 remained highly expressed in 2 cases with low CD117 immunoreactivity. While ISM-1 showed diagnostic sensitivity and specificity comparable to CD117, its distinct nuclear localization provided enhanced morphological clarity for mast cell identification. Cases with high ISM-1 expression showed increased eosinophil counts; however, this trend did not reach statistical significance. These findings suggest that ISM-1 may serve as a complementary immunohistochemical marker for mast cell detection, particularly in diagnostically challenging cases. Moreover, its nuclear staining introduces a novel morphological feature that may improve histopathological assessment of mastocytosis and warrants further investigation in mast cell-associated disorders.

Fields of Study & Subjects

Mast cells and histamine Asthma and respiratory diseases Cell Adhesion Molecules Research

Publication details

Journal / source
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
105
Issue
5
Pages
e47413–e47413
Publication date
30 January 2026
Language
EN